AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Bree, A.
Right arrow Articles by Draijer, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Bree, A.
Right arrow Articles by Draijer, R.
Agricola
Right arrow Articles by de Bree, A.
Right arrow Articles by Draijer, R.
American Journal of Clinical Nutrition, Vol. 86, No. 3, 610-617, September 2007
© 2007 American Society for Nutrition

ORIGINAL RESEARCH COMMUNICATION

Folic acid improves vascular reactivity in humans: a meta-analysis of randomized controlled trials1,2

Angelika de Bree, Linda A van Mierlo and Richard Draijer

1 From Unilever Research and Development, Unilever Food and Health Research Institute, Vlaardingen, Netherlands

Background:The effect of folic acid on endothelial function, a prognostic factor for cardiovascular diseases, is not well established. We calculated this effect in a meta-analysis of randomized, double-blind, placebo-controlled trials in humans.

Objective:The objective of the study was to quantify the effect of folic acid on endothelial function, as measured with the use of flow-mediated dilatation (FMD).

Design:We conducted a meta-analysis of randomized, double-blind, placebo-controlled folic acid trials evaluating endothelial function. Trials were identified through MEDLINE (1966–15 Sept 2005), by hand-searching of references, and by contact with investigators for unpublished results. Two of us (AdB and RD) independently extracted trial data. A pooled estimate was calculated by using random-effects meta-analysis. Previously defined stratified analyses were conducted to explore the influence of study characteristics.

Results:Of 163 identified studies, 14 met inclusion criteria and provided data on 732 persons. Evidence for publication bias was not obvious. In the overall pooled estimate, folic acid improved FMD by 1.08 (95% CI: 0.57,1.59; P = 0.0005) percentage points over placebo. Of the study characteristics, only folic acid dose significantly influenced the outcome. Post hoc analysis, which should be interpreted with caution, seemed to indicate a dose-response effect: the change in FMD was –0.07 (95% CI: –0.37, 0.22) percentage points at doses between 400 and 800 µg/d, 1.37 (95% CI: 1.12, 1.54) percentage points at doses of 5000 µg/d, and 2.04 (95% CI: 1.43, 2.65) percentage points at doses of 10 000 µg/d.

Conclusion:This study indicates that high doses of folic acid improve endothelial function, which could potentially reduce the risk of cardiovascular disease.

Key Words: Folic acid • homocysteine • flow-mediated dilatation • FMD • endothelial function • randomized trial • meta-analysis






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The American Society for Nutrition